Zhengda Biotechnology (03839.HK) announced its interim results, with profit attributable to shareholders of USD 9.423 million, a decrease of 44.72% year-on-year.

Zhitong Finance APP news, Chia Tai Biological (03839.HK) announced its interim results for 2026, with revenue of approximately $211 million, a year-on-year decrease of 34.62%; profit attributable to shareholders was $9.423 million, a year-on-year decrease of 44.72%; earnings per share were 3.7 cents.